The involvement of noncHLAIp in tumor immune recognition was assessed by measuring IFNγ release upon peptide stimulation of autologous tumor-infiltrating lymphocytes (TILs) or peripheral blood mononuclear cells (PBMCs) from the same patient. This evidence concerns the gene IFNG and neoplasm.